Processa Pharmaceuticals, Inc. develops pharmaceutical products aimed at improving survival and quality of life for patients with unmet medical needs. The company focuses on acquiring preclinical and clinical-stage assets, utilizing its regulatory expertise to navigate drugs through the FDA approval process efficiently. Its portfolio is disease agnostic, targeting therapies that demonstrate clinical efficacy and address significant patient needs. Processa engages in partnerships for licensing and commercialization of its drug candidates.
